Mineshima H | Drug Safety Res. Laboratories (kakamigahara) Eisai Co. Ltd.
スポンサーリンク
概要
関連著者
-
Mineshima H
Drug Safety Res. Laboratories (kakamigahara) Eisai Co. Ltd.
-
KURODA Junji
Toxicology Laboratory, Kissei Pharmaceutical Co., Ltd.
-
Hiratsuka K
Graduate School Of Environment And Information Sciences Yokohama National University
-
SUZUKI Tadahiko
Department of Veterinary Medicine, Faculty of Agriculture, Iwate University
-
Kuroda Junji
Toxicology Lab. Kissei Pharmaceutical Co. Ltd.
-
Kuroda J
Toxicology Research Laboratory R&d Kissei Pharmaceutical Co. Ltd.
-
Kuroda Junji
Toxicology
-
Hiratsuka Kazuyuki
Pathology Tsukuba Research Institute Novartis Pharma K. K.
-
Hiratsuka Kazuyuki
Toxicology Lab. Meiji Seika Kaisha Ltd.
-
Hirano Fumiya
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):research & D
-
Numa Toshiaki
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):toxicology Team
-
Endo Y
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):clinical Safety
-
Suzuki Tsuyoshi
Department Of Veterinary Medicine Faculty Of Agriculture Iwate University
-
Nishigaki K
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):fuji Research La
-
Hiratsuka Kazuyuki
Division Of Plant Biotechnology Graduate School Of Environment And Information Sciences Yokohama Nat
-
Matsuzawa T
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma)
-
Suzuki Tadahiko
Department Of Veterinary Pharmacology Faculty Fo Agriculture Iwate University
-
KAWASHITA Hiroto
Toxicology
-
ASADA Yoshihito
Pathology, Tsukuba Research Institute, Novartis Pharma K. k.
-
SUZUKI Tadanori
Toxicology
-
MUGURUMA Yukimi
Pathology, Tsukuba Research Institute, Novartis Pharma K. k.
-
TOMIOKA Satoko
Toxicology
-
TANI Mizuno
Pathology, Tsukuba Research Institute, Novartis Pharma K. k.
-
KONDO Masahide
Toxicology
-
MINESHIMA Hiroshi
Pathology, Tsukuba Research Institute, Novartis Pharma K. k.
-
NAGAE Yusuke
Toxicology
-
Mineshima Hiroshi
Toxicology And Pathology Group Tsukuba Research Institute Novartis Pharma K.k.
-
Nagae Y
Toxicology
-
Ogasawara Hiroyuki
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):medical Research
-
Asada Yoshihito
Pathology Tsukuba Research Institute Novartis Pharma K. K.
-
Muguruma Yukimi
Pathology Tsukuba Research Institute Novartis Pharma K. K.
-
Tani Mizuno
Pathology Tsukuba Research Institute Novartis Pharma K. K.
-
MUGURUMA Yukimi
Toxicology/Pathology, Tsukuba Research Institute, Novartis Pharma K. k.
-
ASADA Yoshihito
Toxicology/Pathology, Tsukuba Research Institute, Novartis Pharma K. k.
-
TANI Mizuno
Toxicology/Pathology, Tsukuba Research Institute, Novartis Pharma K. k.
-
Okuda Yasuyuki
Working Group For Reproductive Toxicology Non-clinical Evaluation Subcommitee Drug Evaluation Commit
-
MINESHIMA Hiroshi
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
NUMA Toshiaki
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
NISHIGAKI Keiji
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
ENDO Yoshihiko
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
OGASAWARA Hiroyuki
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
HIRANO Fumiya
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
MIYAKE Yukio
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
MATSUZAWA Toshiaki
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
MINESHIMA Hiroshi
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
ENDO Yoshihiko
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
OGASAWARA Hiroyuki
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
NISHIGAKI Keiji
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
MATSUZAWA Toshiaki
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
Miyake Yukio
Working Group For Reproductive Toxicology Non-clinical Evaluation Subcommitee Drug Evaluation Commit
-
TOMIOKA Satoko
Toxicology/Pathology, Tsukuba Research Institute, Novartis Pharma K. K.
著作論文
- Se2-2 How pharmaceutical companies meet the ICH guideline for reproductive toxicity studies. : Consideration from a survey carried out by JPMA(Proceedings of the 27th Annual Meeting)
- IMPACT OF GLOBALIZATION UNDER THE ICH GUIDELINES ON THE CONDUCT OF REPRODUCTIVE TOXICITY STUDIES : REPORT ON CURRENT STATUS IN JAPAN, EUROPE AND THE US BY QUESTIONNAIRE SURVEY
- P-82 Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats. : Fadrozole hydrochloride : An oral 2/4-week male reproductive organ toxicity study(Proceedings of the 27th Annual Meeting)
- COLLABORATIVE WORK TO EVALUATE TOXICITY ON MALE REPRODUCTIVE ORGANS BY REPEATED DOSE STUDIES IN RATS : 4)FADROZOLE HYDROCHLORIDE : AN ORAL 2/4-WEEK MALE REPRODUCTIVE ORGAN TOXICITY STUDY